Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced upcoming presentations of six posters highlighting data from their ...
The FDA has granted accelerated approval to Scemblix (asciminib) to treat adults with newly diagnosed Ph+ CML in chronic phase.
Qu and colleagues also analyzed SMA phenotype, serum phosphorus, alkaline phosphatase, and 25-Hydroxyvitamin D levels, but ...
The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...
In a recent article, researchers explored how single-layer graphene oxide (slGO) nanosheets enhance bone marrow stem cell ...
DILIs were identified based on elevated ALT [alanine transaminase], ALP [alkaline phosphatase], and bilirubin laboratory ...
Target patient enrollment of 92 evaluable patients achieved in the VIRAGE Phase 2b clinical trial of VCN-01 in patients with metastatic ...
The study looked at the effect these 2 diets have on fecal microbiota composition, serum metabolomics, and inflammatory ...
Founded on the principles of innovation and patient need, Theriva™ Biologics is a diversified clinical-stage company focused on developing groundbreaking therapeutics to combat cancer and related ...
KEY POINTS A 22-year-old White man presented to the emergency department with a 2-month history of progressive fatigue, intermittent abdominal pain, constipation, and dyspnea. He had gained 27 kg over ...
Syndax Pharmaceuticals and Royalty Pharma plc today announced that Syndax has entered into a $350 million synthetic royalty funding agreement with Royalty Pharma based on U.S. net sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback